Home › Funds › Invenomic Capital Management LP › GPN
Invenomic Capital Management LP position in GPN
GLOBAL PMTS INC · Consumer Discretionary
Invenomic Capital Management LP reported holding 881,579 shares of GPN (GLOBAL PMTS INC) in its Q2 2026 13F filing — a position valued at US$64.0M, representing 3.82% of its reported portfolio and ranking #1 among its reported holdings. Invenomic Capital Management LP has disclosed GPN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Invenomic Capital Management LP's GPN position evolved
Invenomic Capital Management LP first disclosed a stake in GPN in Q3 2023 at 251,571 shares (US$29.0M). The position peaked in Q3 2024 at 682,257 shares, worth US$69.9M. Across 12 filings, Invenomic Capital Management LP increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 881,579 shares valued at US$64.0M — a reduction of -32,926 shares quarter over quarter.. Notable position changes include a 42% increase in Q1 2024 (shares fell 27% over the following quarter), a 129% increase in Q2 2024 (shares rose 4% over the following quarter), a 43% increase in Q3 2024 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 251.57K | $29.03M | New |
| Q4 2023 | 145.82K | $18.52M | Reduce |
| Q1 2024 | 207.63K | $27.75M | Add |
| Q2 2024 | 476.41K | $46.07M | Add |
| Q3 2024 | 682.26K | $69.88M | Add |
| Q4 2024 | 535.45K | $60.00M | Reduce |
| Q1 2025 | 503.97K | $49.35M | Reduce |
| Q2 2025 | 613.02K | $49.07M | Add |
| Q3 2025 | 681.09K | $56.59M | Add |
| Q4 2025 | 797.50K | $61.73M | Add |
| Q1 2026 | 914.50K | $61.55M | Add |
| Q2 2026 | 881.58K | $63.97M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GPN and 13F data
GPN (GLOBAL PMTS INC) is a Consumer Discretionary company. 13 other funds we track also report a position in GPN — the largest reported positions include GTCR LLC (US$3.14B), Harris Associates (Oakmark) (US$937.0M), HARRIS ASSOCIATES L P (US$937.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GPN
- GTCR LLC 43.27M sh · $3.14B · Q2 2026
- Harris Associates (Oakmark) 12.91M sh · $936.97M · Q2 2026
- HARRIS ASSOCIATES L P 12.91M sh · $936.97M · Q2 2026
- Pzena Investment Management 11.69M sh · $848.34M · Q2 2026
- GLENVIEW CAPITAL MANAGEMENT, LLC 8.91M sh · $646.27M · Q2 2026
- Pinnacle Financial Partners, Inc. 6.94M sh · $503.44M · Q2 2026
- Soros Fund Management 247.50M sh · $222.69M · Q2 2026
More on Invenomic Capital Management LP
FAQ
How long has Invenomic Capital Management LP held GPN?
Invenomic Capital Management LP has disclosed GPN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Invenomic Capital Management LP's current position in GPN?
As of Q2 2026, Invenomic Capital Management LP holds 881.58K shares of GPN (GLOBAL PMTS INC), valued at $63.97M, representing 3.82% of its reported portfolio and ranking #1.
Has Invenomic Capital Management LP been buying or selling GPN?
In the latest 13F filing (Q2 2026), Invenomic Capital Management LP reduced its position in GPN. The position peaked in Q3 2024 at 682.26K shares.
Which other funds hold GPN?
Other major institutional holders of GPN include GTCR LLC, Harris Associates (Oakmark), HARRIS ASSOCIATES L P, among 13 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.